Yu-Ru Lee
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- PI3K/AKT/mTOR signaling in cancer
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 6
- PI3K/AKT/mTOR signaling in cancer 4
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
-
- Synthesis and biological activity 4
- Co-authors
- Pier Paolo Pandolfi (6 shared papers)Ming Chen (1 shared paper)Ruey‐Hwa Chen (6 shared papers)Wei-Chien Yuan (4 shared papers)Hsin‐Yi Chen (2 shared papers)John G. Clohessy (2 shared papers)Jonathan D. Lee (2 shared papers)Assaf C. Bester (1 shared paper)
- Journals
- Molecular Cell (3 papers)Fermentation (2 papers)Arabian Journal of Chemistry (2 papers)PLoS ONE (2 papers)Nature Methods (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Yu-Ru Lee
31 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 444
- Molecular Biology 1.4k
- Oncology 344
- Toxicology 31
- Cell Biology 148
Countries citing papers authored by Yu-Ru Lee
This map shows the geographic impact of Yu-Ru Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Ru Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Ru Lee more than expected).
Fields of papers citing papers by Yu-Ru Lee
This network shows the impact of papers produced by Yu-Ru Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Ru Lee. The network helps show where Yu-Ru Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu-Ru Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The functions and regulation of the PTEN tumour suppressor: new modes and prospects Hit paper breakdown → | 2018 | 645 |
| 2 | 2018 | 237 | |
| 3 | 2011 | 149 | |
| 4 | 2014 | 132 | |
| 5 | 2010 | 102 | |
| 6 | 2007 | 65 | |
| 7 | 2019 | 61 | |
| 8 | 2020 | 53 | |
| 9 | 2013 | 45 | |
| 10 | 1999 | 38 | |
| 11 | 2024 | 35 | |
| 12 | 2012 | 31 | |
| 13 | 2015 | 30 | |
| 14 | 1997 | 28 | |
| 15 | 2013 | 24 | |
| 16 | 2019 | 19 | |
| 17 | 2021 | 17 | |
| 18 | 2016 | 16 | |
| 19 | 2005 | 15 | |
| 20 | 2017 | 15 |
About Yu-Ru Lee
Yu-Ru Lee is a scholar working on Molecular Biology, Organic Chemistry, Cancer Research, Biomedical Engineering and Oncology, having authored 31 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Synthesis and biological activity (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Cancer therapeutics and mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Algal biology and biofuel production (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Cancer Research (444 citations), Molecular Biology (1.4k citations), Oncology (344 citations), Toxicology (31 citations) and Cell Biology (148 citations). Yu-Ru Lee has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Pier Paolo Pandolfi, Ming Chen, Ruey‐Hwa Chen, Wei-Chien Yuan, Hsin‐Yi Chen, John G. Clohessy, Jonathan D. Lee, Assaf C. Bester, Paolo Provero and Emanuele Monteleone. Their work appears in journals such as Molecular Cell, Fermentation, Arabian Journal of Chemistry, PLoS ONE and Nature Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.